A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform.

The scrapie prion protein (PrPSc) is formed from the cellular isoform (PrPC) by a post-translational process that involves a profound conformational change. Linear epitopes for recombinant antibody Fab fragments (Fabs) on PrPC and on the protease-resistant core of PrPSc, designated PrP 27-30, were identified using ELISA and immunoprecipitation. An epitope region at the C terminus was accessible in both PrPC and PrP 27-30; in contrast, epitopes towards the N-terminal region (residues 90 to 120) were accessible in PrPC but largely cryptic in PrP 27-30. Denaturation of PrP 27-30 exposed the epitopes of the N-terminal domain. We argue from our findings that the major conformational change underlying PrPSc formation occurs within the N-terminal segment of PrP 27-30.

[1]  F. Cohen,et al.  Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F E Cohen,et al.  Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Cohen,et al.  Recombinant scrapie-like prion protein of 106 amino acids is soluble. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Prusiner,et al.  Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.

[5]  D R Burton,et al.  In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope , 1996, Journal of virology.

[6]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[7]  D R Burton,et al.  Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  F. Cohen,et al.  High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. , 1996, Biochemistry.

[9]  P. Pergami,et al.  Semipreparative chromatographic method to purify the normal cellular isoform of the prion protein in nondenatured form. , 1996, Analytical biochemistry.

[10]  F. Cohen,et al.  Prion protein structure and scrapie replication: theoretical, spectroscopic, and genetic investigations. , 1996, Cold Spring Harbor symposia on quantitative biology.

[11]  F E Cohen,et al.  Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Cohen,et al.  Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein , 1995, Cell.

[13]  Fred E. Cohen,et al.  Conformational Transformations in Peptides Containing Two Putative α-Helices of the Prion Protein , 1995 .

[14]  F. Cohen,et al.  Prion protein gene variation among primates. , 1995, Journal of molecular biology.

[15]  F. Cohen,et al.  Scrapie prions: a three-dimensional model of an infectious fragment. , 1995, Folding & design.

[16]  R. Marsh,et al.  Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy , 1994, Journal of virology.

[17]  F. Cohen,et al.  Proposed three-dimensional structure for the cellular prion protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D R Burton,et al.  Human antibodies from combinatorial libraries. , 1994, Advances in immunology.

[19]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Roller,et al.  Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity , 1993, Protein science : a publication of the Protein Society.

[21]  S. Prusiner,et al.  Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D R Burton,et al.  Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Fletterick,et al.  Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Prusiner,et al.  Regional mapping of prion proteins in brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Prusiner,et al.  Evidence for synthesis of scrapie prion proteins in the endocytic pathway. , 1992, The Journal of biological chemistry.

[26]  S. Prusiner,et al.  Epitope mapping of the Syrian hamster prion protein utilizing chimeric and mutant genes in a vaccinia virus expression system. , 1991, Journal of immunology.

[27]  D R Burton,et al.  A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Barbas,et al.  Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Caughey,et al.  Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.

[30]  U. Pettersson,et al.  Adenovirus E4-dependent activation of the early E2 promoter is insufficient to promote the early-to-late-phase transition , 1991, Journal of virology.

[31]  S. Prusiner,et al.  Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis , 1991, Journal of virology.

[32]  S. Prusiner,et al.  Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells , 1990, The Journal of cell biology.

[33]  D R Burton,et al.  Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. , 1989, Science.

[34]  S. Prusiner,et al.  Prion protein gene expression in cultured cells. , 1988, Protein engineering.

[35]  H. Wiśniewski,et al.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins , 1987, Journal of virology.

[36]  S. Prusiner,et al.  Purified prion proteins and scrapie infectivity copartition into liposomes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Prusiner,et al.  Monoclonal antibodies to the cellular and scrapie prion proteins. , 1986, The Journal of infectious diseases.

[38]  H. Gelderblom,et al.  Characterization of antisera against scrapie-associated fibrils (SAF) from affected hamster and cross-reactivity with SAF from scrapie-affected mice and from patients with Creutzfeldt-Jakob disease. , 1985, The Journal of general virology.

[39]  H. Diringer,et al.  Absence of autoantibodies against neurofilament proteins in the sera of scrapie infected mice. , 1985, The Tohoku journal of experimental medicine.

[40]  S. Prusiner,et al.  Antibodies to a scrapie prion protein , 1984, Nature.

[41]  S. Prusiner,et al.  Scrapie prions aggregate to form amyloid-like birefringent rods , 1983, Cell.

[42]  D. Hart,et al.  Hamster Immune Responses in Infectious and Oncologic Diseases , 2012, Advances in Experimental Medicine and Biology.

[43]  S. Prusiner,et al.  Determination of scrapie agent titer from incubation period measurements in hamsters. , 1981, Advances in experimental medicine and biology.

[44]  D. Haig,et al.  Attempts to demonstrate neutralising antibodies in the sera of scrapie-affected animals , 1966, Veterinary Record.